Two Sigma Investments, LP Aurinia Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$7.13 - $9.49 $3.24 Million - $4.32 Million	-454,720 Reduced 72.37%	173,600 $1.56 Million
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $5.75 Million - $9.08 Million	-739,851 Reduced 54.08%	628,320 $4.88 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $5.78 Million - $7.54 Million	644,569 Added 89.08%	1,368,171 $13.2 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $584,668 - $1.11 Million	98,429 Added 15.74%	723,602 $7.93 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $414,809 - $821,545	100,927 Added 19.25%	625,173 $2.7 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $3.49 Million - $6.5 Million	524,246 New	524,246 $3.94 Million
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $141,033 - $174,928	-10,899 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $143,757 - $181,577	10,899 New	10,899 $161,000
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $347,337 - $450,899	-24,599 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $278,952 - $527,894	24,599 New	24,599 $357,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.